No actionable signal from these director sales given the trivial dollar amounts relative to market cap. Continue monitoring for any C-suite open-market transactions or cluster buying activity, which would carry stronger informational content.
LGND drugs
LGND drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 15 $253.25entry
- T+1 · 5mo ago +0.79%α +1.39% · $255.25
- T+5 · 5mo ago +3.52%α +4.91% · $262.17
- T+20 · 4mo ago +22.11%α +22.86% · $309.25
- T+60 · 2mo ago +13.74%α +12.74% · $288.05
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the company's $5.1B market cap. These open-market sales are trivial relative to market cap and likely reflect routine portfolio diversification, no material signal for the stock.
Key Financial Metrics
Key Facts
- Director Aryeh Jason sold 5,000 shares total on June 10-11, 2026 (~$1.25M)
- Director John L. Lamattina sold 257 shares on June 10, 2026 (~$63.5K)
- Total insider sales of ~$1.31M represent only 0.026% of LGND's $5.1B market cap
- All sellers are directors, not C-suite executives, signal weight is lower per academic literature
Financial Impact
Negligible, $1.31M is 0.026% of market cap, well below the 0.1% materiality threshold
Risk Factors
- No material risk identified from this insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1781299717319 |
Track record
29 reports on LGND
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers